|
|
Volumn 7, Issue 3, 2012, Pages 339-341
|
|
Challenges and Opportunities in Neuroscience Research
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CENTRAL NERVOUS SYSTEM AGENTS;
OREXIN;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
TRACER;
ALZHEIMER DISEASE;
BIPOLAR DISORDER;
BRAIN;
BRAIN FUNCTION;
CENTRAL NERVOUS SYSTEM DISEASE;
CEREBROSPINAL FLUID;
COST;
DEPRESSION;
DRUG INDUSTRY;
EDITORIAL;
ELECTROENCEPHALOGRAM;
ELECTROENCEPHALOGRAPHY;
FUNCTIONAL MAGNETIC RESONANCE IMAGING;
GENE MUTATION;
GENETIC ASSOCIATION;
GENETIC HETEROGENEITY;
HEALTH CARE COST;
HEALTH CARE QUALITY;
HUMAN;
INVESTMENT;
MAGNETOENCEPHALOGRAPHY;
MEDICAL RESEARCH;
MEDICINE;
MENTAL DISEASE;
MICRODIALYSIS;
NEUROLOGIC DISEASE;
NEUROSCIENCE;
NONHUMAN;
PARKINSON DISEASE;
PATHOPHYSIOLOGY;
POSITRON EMISSION TOMOGRAPHY;
PREDICTIVE VALIDITY;
PREVALENCE;
PRIORITY JOURNAL;
RECEPTOR AFFINITY;
RISK;
SCHIZOPHRENIA;
SIGNAL NOISE RATIO;
SLEEP DISORDER;
BIOMEDICAL RESEARCH;
CENTRAL NERVOUS SYSTEM AGENTS;
DRUG DISCOVERY;
HUMANS;
NEURODEGENERATIVE DISEASES;
NEUROSCIENCES;
|
|
EID: 84857777860
PISSN: 18607179
EISSN: 18607187
Source Type: Journal
DOI: 10.1002/cmdc.201200075 Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
